Former Research Analyst at Goldman Sachs & Co. LLC
This person is connected to 879 people.
President, Chief Executive Officer & Chairman of the Board at Stellar Biotechnologies Inc.
Professor Emeritus at University of California - Santa Barbara
Scientific Director at Art Reproductive Center
Former Controller at ZPower LLC
Former Vice President-CMC & Technical Operations at NGM Biopharmaceuticals, Inc.
Former Controller at ZPower LLC
Executive Vice President of Corporate Development at Stellar Biotechnologies Inc.
Chairman & General Manager at Amaran Biotechnology, Inc.
Founder at Praecis Pharmaceuticals, Inc.
Chief Financial Officer & Corporate Secretary at Stellar Biotechnologies Inc.
Paths to Paul Chun
Connections via Relationship Science
Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.
Amgen Ventures LLC invests in biotechnology companies located in North America, Europe and the UK. It focuses companies operating in the fields of discovering and developing human therapeutics. It make financing for early stage capital requirements and invests up to $3 to $5 million per round with $15 million over the life of the company.
Prior - 2007
Goldman, Sachs & Co. (GS&Co.), a limited partnership registered as a U.S. broker-dealer and futures commission merchant, together with its consolidated subsidiaries (collectively, the firm), is an indirectly wholly owned subsidiary of The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation. The firm is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.
Tavistock Life Sciences Co. (TLS) invests in a select number of public and private companies that possess both compelling science and the potential to generate significant commercial rewards. The firm focuses on investments in life science companies with exceptional technology profiles. They seek opportunities to partner with scientists, founders and inventors in early-stage biotechnology opportunities
Boards & Committees
Member, Board of Directors
2016 - Current
Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin protein under the brand Stellar KLH. Its product portfolio includes Stellar KLH™ Products, Stellar KLH™ Protein, and Stellar KLH™ ELISA Kits. The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA.
You've reached your 7 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!